Cvs Pharmacy #05914 Durable Medical Equipment & Medical Supplies Location: 445 West Street Rd, Warminster, Pennsylvania 18974 Phone: (215) 674-2297 |
Cvs Pharmacy #00658 Durable Medical Equipment & Medical Supplies Location: 7 York Road, Warminster, Pennsylvania 18974 Phone: (215) 443-8113 |
Cvs Pharmacy #48564 Durable Medical Equipment & Medical Supplies Location: 30000 Anns Choice Way, Warminster, Pennsylvania 18974 Phone: (215) 347-2097 |
Rite Aid Pharmacy 00293 Durable Medical Equipment & Medical Supplies Location: 599 York Rd, Warminster, Pennsylvania 18974 Phone: (215) 674-0122 |
Walgreens #4356 Durable Medical Equipment & Medical Supplies Location: 10 York Rd, Warminster, Pennsylvania 18974 Phone: (215) 956-2834 |
Sunrise Home Health Care Durable Medical Equipment & Medical Supplies Location: 1822 Mearns Rd, Warminster, Pennsylvania 18974 Phone: (215) 956-9080 |
Medicine Shoppe 0629 Pharmacy Location: 95 York Rd, Warminster, Pennsylvania 18974 Phone: (215) 675-0777 |
Walmart Pharmacy 10-2096 Durable Medical Equipment & Medical Supplies Location: 100 E Street Rd, Warminster, Pennsylvania 18974 Phone: (215) 442-5608 |
Shop Rite Pharmacy Community/Retail Pharmacy Location: 942w Street Rd, Warminster, Pennsylvania 18974 Phone: (215) 328-4707 |
Shuckert Shoes Prosthetic/Orthotic Supplier Location: 607 Louis Dr, Warminster, Pennsylvania 18974 Phone: (215) 794-2600 |
Pearle Vision Center Medicare Supplier Location: 632 York Rd, Warminster, Pennsylvania 18974 Phone: (215) 674-5700 |
News Archive
Ordinary human cells reprogrammed as induced pluripotent stem cells may ultimately revolutionize personalized medicine by creating new and diverse therapies unique to individual patients.
Soccer training can significantly reduce blood pressure and improve aerobic fitness in hypertensive middle-aged men, researchers say.
In six short weeks, FuelCo, which operates various retail and convenience stores throughout Connecticut and New York, sold $20,000 worth of scannable cards recently to benefit the cure-focused work of the Diabetes Research Institute.
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.
› Verified 1 days ago